greater scrutiny of propoxyphene (Darvocet, Darvon, etc)

March 2009

See new information from the FDA concerning the withdrawal of propoxyphene from the U.S. market

You'll see greater scrutiny of propoxyphene (Darvocet, Darvon, etc)...and a move toward a possible ban by the FDA.

It's already banned in the U.K...and is rarely used in Canada.

But it's still among the top 25 prescribed drugs in the U.S.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

greater scrutiny of propoxyphene (Darvocet, Darvon, etc)
Cardiology The metoprolol shortage will cause more questions on how to switch
Cardiology Is chlorthalidone better than hydrochlorothiazide
Bisphosphonates osteonecrosis of the jaw in patients taking bisphosphonates for osteoporosis
Gastroenterology new proton pump inhibitor called Kapidex
Diabetes New Am Diabetes Assoc guidelines emphasize a more "personal" approach to setting goals for glycemic control
Poison Prevention safety of topical camphor and menthol products (Vicks VapoRub, etc) in kids
Pediatrics whether oral corticosteroids are beneficial for wheezing in PRESCHOOLERS
Vaccines Parents continue to have fears about pediatric vaccines
Respiratory & Allergy new nasal spray for allergic rhinitis called Astepro
Fibromyalgia ads promoting Savella (milnacipran) as the first drug approved ONLY for fibromyalgia